Literature DB >> 25952005

Association analysis revealed one susceptibility locus for vitiligo with immune-related diseases in the Chinese Han population.

Shu Li1, Weiyi Yao, Qian Pan, Xianfa Tang, Suli Zhao, Wenjun Wang, Zhengwei Zhu, Jinping Gao, Yujun Sheng, Fusheng Zhou, Xiaodong Zheng, Xianbo Zuo, Liangdan Sun, Anping Zhang.   

Abstract

Generalized vitiligo is an autoimmune disease characterized by melanocyte loss, which results in patchy depigmentation of skin and hair, and is associated with an elevated risk of other immune-related diseases. However, there is no reported study on the associations between immune susceptibility polymorphisms and the risk of vitiligo with immune-related diseases. The aim of this study was to evaluate the potential influence of 10 single-nucleotide polymorphisms (SNPs) at 18q21.31 (rs10503019), 4p16.1 (rs11940117), 3q28 (rs1464510), 14q12 (rs2273844), 12q13.2 (rs2456973), 16q12.2 (rs3213758), 10q25.3 (rs4353229), 3q13.33 (rs59374417), and 10p15.1 (rs706779 and rs7090530) on vitiligo with immune-related diseases in the Chinese Han population. All SNPs were genotyped in 552 patients with vitiligo-associated immune-related diseases and 1656 controls using the Sequenom MassArray system. Data were analyzed with PLINK 1.07 software. The C allele of rs2456973 at 12q13.2 was observed to be significantly associated with vitiligo-associated immune-related diseases (autoimmune diseases and allergic diseases) (P = 0.0028, odds ratio (OR) = 1.27). In subphenotype analysis, the rs2456973 C allele was also significantly associated with early-onset vitiligo by comparing with controls (P = 0.0001) and in the case-only analysis (P = 0.0114). We confirmed that 12q13.2 was an important candidate locus for vitiligo with immune-related diseases (autoimmune diseases and allergic diseases) and affected disease phenotypes with early onset.

Entities:  

Mesh:

Year:  2015        PMID: 25952005     DOI: 10.1007/s00251-015-0843-4

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  29 in total

1.  A novel linkage to generalized vitiligo on 4q13-q21 identified in a genomewide linkage analysis of Chinese families.

Authors:  Jian-Jun Chen; Wei Huang; Jin-Ping Gui; Sen Yang; Fu-Sheng Zhou; Quan-Geng Xiong; Hong-Bo Wu; Yong Cui; Min Gao; Wei Li; Jin-Xian Li; Kai-Lin Yan; Wen-Tao Yuan; Shi-Jie Xu; Jian-Jun Liu; Xue-Jun Zhang
Journal:  Am J Hum Genet       Date:  2005-04-04       Impact factor: 11.025

2.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  Association between vitiligo and atopic disorders: a pilot study.

Authors:  Jonathan I Silverberg; Nanette B Silverberg
Journal:  JAMA Dermatol       Date:  2013-08       Impact factor: 10.282

Review 4.  Recent progress in the genetics of generalized vitiligo.

Authors:  Richard A Spritz
Journal:  J Genet Genomics       Date:  2011-06-12       Impact factor: 4.275

5.  Common variants in FOXP1 are associated with generalized vitiligo.

Authors:  Ying Jin; Stanca A Birlea; Pamela R Fain; Christina M Mailloux; Sheri L Riccardi; Katherine Gowan; Paulene J Holland; Dorothy C Bennett; Margaret R Wallace; Wayne T McCormack; E Helen Kemp; David J Gawkrodger; Anthony P Weetman; Mauro Picardo; Giovanni Leone; Alain Taïeb; Thomas Jouary; Khaled Ezzedine; Nanny van Geel; Jo Lambert; Andreas Overbeck; Richard A Spritz
Journal:  Nat Genet       Date:  2010-06-06       Impact factor: 38.330

6.  A novel susceptibility locus for type 1 diabetes on Chr12q13 identified by a genome-wide association study.

Authors:  Hakon Hakonarson; Hui-Qi Qu; Jonathan P Bradfield; Luc Marchand; Cecilia E Kim; Joseph T Glessner; Rosemarie Grabs; Tracy Casalunovo; Shayne P Taback; Edward C Frackelton; Andrew W Eckert; Kiran Annaiah; Margaret L Lawson; F George Otieno; Erin Santa; Julie L Shaner; Ryan M Smith; Chioma C Onyiah; Robert Skraban; Rosetta M Chiavacci; Luke J Robinson; Charles A Stanley; Susan E Kirsch; Marcella Devoto; Dimitri S Monos; Struan F A Grant; Constantin Polychronakos
Journal:  Diabetes       Date:  2008-01-15       Impact factor: 9.461

Review 7.  Vitiligo and allergic complications from orthopaedic joint implants: the role of benzoyl peroxide.

Authors:  Marcel Dudda; Peter Godau; Sammy Al-Benna; Thomas A Schildhauer; Martin Gothner
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2013-05

8.  Genetic variation of promoter sequence modulates XBP1 expression and genetic risk for vitiligo.

Authors:  Yunqing Ren; Sen Yang; Shengxin Xu; Min Gao; Wei Huang; Tianwen Gao; Qiaoyun Fang; Cheng Quan; Chi Zhang; Liangdan Sun; Yanhua Liang; Jianwen Han; Zhimin Wang; Fengyu Zhang; Youwen Zhou; Jianjun Liu; Xuejun Zhang
Journal:  PLoS Genet       Date:  2009-06-19       Impact factor: 5.917

9.  Three new single nucleotide polymorphisms identified by a genome-wide association study in Korean patients with vitiligo.

Authors:  Kyung Ah Cheong; Nan-Hyung Kim; Minsoo Noh; Ai-Young Lee
Journal:  J Korean Med Sci       Date:  2013-05-02       Impact factor: 2.153

10.  BACH2 represses effector programs to stabilize T(reg)-mediated immune homeostasis.

Authors:  Rahul Roychoudhuri; Kiyoshi Hirahara; Kambiz Mousavi; David Clever; Christopher A Klebanoff; Michael Bonelli; Giuseppe Sciumè; Hossein Zare; Golnaz Vahedi; Barbara Dema; Zhiya Yu; Hui Liu; Hayato Takahashi; Mahadev Rao; Pawel Muranski; Joseph G Crompton; George Punkosdy; Davide Bedognetti; Ena Wang; Victoria Hoffmann; Juan Rivera; Francesco M Marincola; Atsushi Nakamura; Vittorio Sartorelli; Yuka Kanno; Luca Gattinoni; Akihiko Muto; Kazuhiko Igarashi; John J O'Shea; Nicholas P Restifo
Journal:  Nature       Date:  2013-06-02       Impact factor: 49.962

View more
  6 in total

1.  Interactome analysis of gene expression profile reveals potential novel key transcriptional regulators of skin pathology in vitiligo.

Authors:  R Dey-Rao; A A Sinha
Journal:  Genes Immun       Date:  2015-11-12       Impact factor: 2.676

2.  Vitiligo blood transcriptomics provides new insights into disease mechanisms and identifies potential novel therapeutic targets.

Authors:  Rama Dey-Rao; Animesh A Sinha
Journal:  BMC Genomics       Date:  2017-01-28       Impact factor: 3.969

3.  Validation of Susceptibility Loci for Vitiligo Identified by GWAS in the Chinese Han Population.

Authors:  Lu Cheng; Bo Liang; Xian-Fa Tang; Xin-Ying Cai; Hui Cheng; Xiao-Dong Zheng; Jie Zheng; Meng-Wei Wang; Jun Zhu; Fu-Sheng Zhou; Pan Li; Feng-Li Xiao
Journal:  Front Genet       Date:  2020-12-03       Impact factor: 4.599

4.  Autoimmune vitiligo in rheumatic disease in the mestizo Mexican population.

Authors:  Esperanza Avalos-Díaz; Elena Pérez-Pérez; Mayra Rodríguez-Rodríguez; María-Guadalupe Pacheco-Tovar; Rafael Herrera-Esparza
Journal:  Biomed Rep       Date:  2016-06-03

5.  Systematic analysis of genetic variants in Han Chinese patients with sporadic Parkinson's disease.

Authors:  Lamei Yuan; Zhi Song; Xiong Deng; Wen Zheng; Yi Guo; Zhijian Yang; Hao Deng
Journal:  Sci Rep       Date:  2016-09-22       Impact factor: 4.379

6.  Granzyme B prevents aberrant IL-17 production and intestinal pathogenicity in CD4+ T cells.

Authors:  Michael J Greer; Kathleen G McClanahan; Kristen L Hoek; Ali Nazmi; M Blanca Piazuelo; Kshipra Singh; Keith T Wilson; Danyvid Olivares-Villagómez
Journal:  Mucosal Immunol       Date:  2021-06-28       Impact factor: 7.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.